Polymeric nanomaterial strategies to encapsulate and deliver biological drugs: points to consider between methods
Year: 2023
Type: review
Abstract: Biological drugs (BDs) play an increasingly irreplaceable role in treating various diseases such as cancer, and cardiovascular and neurodegenerative diseases. The market share of BDs is increasingly promising. However, the effectiveness of BDs is currently limited due to challenges in efficient administration and delivery, and issues with stability and degradation. Thus, the field is using nanotechnology to overcome these limitations. Specifically, polymeric nanomaterials are common BD carriers due to their biocompatibility and ease of synthesis. Different strategies are available for BD transportation, but the use of core-shell encapsulation is preferable for BDs. This review discusses recent articles on manufacturing methods for encapsulating BDs in polymeric materials, including emulsification, nanoprecipitation, self-encapsulation and coaxial electrospraying. The advantages and disadvantages of each method are analysed and discussed. We also explore the impact of critical synthesis parameters on BD activity, such as sonication in emulsifications. Lastly, we provide a vision of future challenges and perspectives for scale-up production and clinical translation.
Source: Biomaterials Science
DOI: 10.1039/d2bm01594c
Institutions: Griffith University, The University of Queensland
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: bronze
Awards: G1262863226, Bifunctionalised imaging agents for diagnosis and treatment of cardiovascular and inflammatory diseases, Developing smart nanomedicine to enable advanced diagnosis and stimuli-responsive treatment for atherosclerosis and thrombosis, G382583574, Innovative Reversible Hemostatic Nanomaterial for Emergency Treatment of Internal Bleeding, G7835754168, G8001222757
OpenAlex ID: W4315783114
